GRAND RAPIDS, Mich. — The FDA has issued an emergency use authorization for convalescent blood plasma therapy to treat Covid-19 saying the "known and potential benefits of the product outweigh the known and potential risks of the product."
Dr. Gordana Simeunovic, a Spectrum Health expert on convalescent plasma therapy talks with 13 On Your Side Health Reporter Val Lego about the FDA decision, whether is truly cuts mortality rates by 35% and how new antibody testing at blood collection centers is helping West Michigan.
►Make it easy to keep up to date with more stories like this. Download the 13 ON YOUR SIDE app now.
Have a news tip? Email news@13onyourside.com, visit our Facebook page or Twitter. Subscribe to our YouTube channel.